Cargando…
Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”
Autores principales: | Wang, Bi-Cheng, Xiao, Bo-Ya, Li, Peng-Cheng, Kuang, Bo-Hua, Chen, Wang-Bing, Li, Pin-Dong, Lin, Guo-He, Liu, Quentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935607/ https://www.ncbi.nlm.nih.gov/pubmed/33727920 http://dx.doi.org/10.1155/2021/3735726 |
Ejemplares similares
-
Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
por: Wang, Bi-Cheng, et al.
Publicado: (2020) -
CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy
por: Garrido, MJ, et al.
Publicado: (2017) -
Corrigendum to “Potential Extensions of the US FRAX Algorithm”
por: Osteoporosis, Journal of
Publicado: (2018) -
Distal Extension Denture – Case Report and Overview [Corrigendum]
Publicado: (2021) -
Corrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
por: D'Angelo, S. P., et al.
Publicado: (2015)